Daily Ginger Drinking and Platelet Function
The Effect of Daily Ginger Drinking on Platelet's Function in the Saudi Population
1 other identifier
interventional
40
1 country
1
Brief Summary
This study aims to examine the effect of ginger beverage consumption on platelets activity in apparently healthy Saudi adult volunteers. As for the Saudi population, consumption of powdered ginger dissolved in hot water is a common practice. Accordingly, in this study, it is tempting to speculate the effect of this form of ginger consumption, given in separate time points per day, on platelet aggregation profile by using platelet aggregation analogues. If positive results were obtained, the herb could provide natural protection against the development of platelet aggregation complications and could be a potential alternative to aspirin, used for improving blood circulation and hematological pathophysiologies in diseased individuals.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2013
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2016
CompletedFirst Submitted
Initial submission to the registry
August 10, 2016
CompletedFirst Posted
Study publicly available on registry
August 30, 2016
CompletedAugust 30, 2016
August 1, 2016
2.6 years
August 10, 2016
August 24, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
The effect of ginger beverage consumption on platelets activity will be examined in apparently healthy, Saudi adult volunteers.
1 year
Secondary Outcomes (4)
The demographic characteristics of the sample under study will be identified.
1 year
Any change in platelet morphology before and after ginger consumption will be studied
1 year
Platelets' count before and after ginger consumption will be compared.
1 year
Any change in platelets function after ginger consumption via addition of aggregation analogues will be studied.
1 year
Study Arms (2)
Ginger drink once daily
OTHERthis group will receive ginger drink made by dissolving 4g ginger powder in plain water once a day for continuous 5 days.
Ginger drink twice daily
OTHERthis group will receive ginger drink made by dissolving 4g ginger powder in plain water twice a day for continuous 5 days.
Interventions
Ginger powder dissolved in water
Eligibility Criteria
You may qualify if:
- Apparently healthy Saudi volunteers of either sex
- Age group = 18-60 years.
You may not qualify if:
- History of organ abnormalities or concomitant illnesses.
- Abnormal platelets count or function.
- Individuals with bleeding disorder as Von Willebrand Disorder or Hemophilia.
- Known allergy to ginger.
- Concurrent warfarin ingestion.
- History of ingestion of asprin,clopidogrel, nifedipine, non-steroid anti-inflammatory drugs (NSAIDs) or ethanol within the past two week.
- Any volunteer ingests ethanol, aspirin, clopidogrel, wine, beer and contraceptive pills during the study duration will be excluded from the study.
- pregnant \& lactating women.
- Individuals on herbal treatment.
- Active G.I ulcers/ recently diagnosed G.I ulcers within one month
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
King Abdulaziz Medical City - National Guard Hospital
Riyadh, Central, 11426, Saudi Arabia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dr. Askar S. Alaskar, MD,FACP,FRCP
King Abdullah Medical research Center - King Abdulaziz Medical City - Riyadh
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 10, 2016
First Posted
August 30, 2016
Study Start
December 1, 2013
Primary Completion
July 1, 2016
Study Completion
July 1, 2016
Last Updated
August 30, 2016
Record last verified: 2016-08
Data Sharing
- IPD Sharing
- Will share
Undecided